세계의 폴리데옥시리보뉴클레오티드(PDRN) 시장(2023년)

The global Polydeoxyribonudeotide (PDRN) market was valued at US$ 25.82 million in 2022 and is anticipated to reach US$ 286.32 million by 2029, witnessing a CAGR of 43.39% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Europe market for Polydeoxyribonudeotide (PDRN) is estimated to increase from $ 8.08 million in 2023 to reach $ 64.19 million by 2029, at a CAGR of 41.26% during the forecast period of 2023 through 2029.

China market for Polydeoxyribonudeotide (PDRN) is estimated to increase from $ 13.43 million in 2023 to reach $ 132.32 million by 2029, at a CAGR of 46.42% during the forecast period of 2023 through 2029.

South Korea market for Polydeoxyribonudeotide (PDRN) is estimated to increase from $ 10.93 million in 2023 to reach $ 84.26 million by 2029, at a CAGR of 40.55% during the forecast period of 2023 through 2029.

The major global manufacturers of Polydeoxyribonudeotide (PDRN) include: HTL Biotechnology, Ruijiming Biological, PharmaResearch Co., Ltd., Humedix, ReaLi Tide Biological, HENGYU BIOPH, Mastelli, Dongkook, BR PHARM, BMI KOREA, BNF Solution, etc. In 2022, the world's top three vendors accounted for approximately 55.53% of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Polydeoxyribonudeotide (PDRN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polydeoxyribonudeotide (PDRN).

The Polydeoxyribonudeotide (PDRN) market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Polydeoxyribonudeotide (PDRN) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Polydeoxyribonudeotide (PDRN) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

• HTL Biotechnology
• Ruijiming Biological
• PharmaResearch Co., Ltd.
• Humedix
• ReaLi Tide Biological
• HENGYU BIOPH
• Mastelli
• Dongkook
• BR PHARM
• BMI KOREA
• BNF Solution

Segment by Type

• Powder
• Solution

Segment by Application

• Mesotherapy
• Bone Injection & Dermal Fillers
• Pharmaceutical
• Cosmetic
• Wound Healing Products & Others

Production by Region

• Europe
• China
• South Korea
• Others

Consumption by Region

• North America
  • U.S.
  • Canada

• Asia-Pacific
  • China
  • South Korea
  • Others

• Europe
  • Italy
  • France
  • Rest of Europe

Core Chapters

• Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

• Chapter 2: Detailed analysis of Polydeoxyribonudeotide (PDRN) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

• Chapter 3: Production/output, value of Polydeoxyribonudeotide (PDRN) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

• Chapter 4: Consumption of Polydeoxyribonudeotide (PDRN) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

• Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

• Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

• Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

• Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

• Chapter 10: The main points and conclusions of the report.

Table of Contents

1 Polydeoxyribonudeotide (PDRN) Market Overview

• 1.1 Product Definition
• 1.2 Polydeoxyribonudeotide (PDRN) by Type
  • 1.2.1 Global Polydeoxyribonudeotide (PDRN) Market Value Growth Rate Analysis by Type: 2022 VS 2029
  • 1.2.2 Powder
  • 1.2.3 Solution
• 1.3 Polydeoxyribonudeotide (PDRN) by Application
  • 1.3.1 Global Polydeoxyribonudeotide (PDRN) Market Value Growth Rate Analysis by Application: 2022 VS 2029
  • 1.3.2 Mesotherapy
  • 1.3.3 Bone Injection & Dermal Fillers
  • 1.3.4 Pharmaceutical
  • 1.3.5 Cosmetic
  • 1.3.6 Wound Healing Products & Others
• 1.4 Global Market Growth Prospects
  • 1.4.1 Global Polydeoxyribonudeotide (PDRN) Production Value Estimates and Forecasts (2018-2029)
  • 1.4.2 Global Polydeoxyribonudeotide (PDRN) Production Estimates and Forecasts (2018-2029)
  • 1.4.3 Global Polydeoxyribonudeotide (PDRN) Market Average Price Estimates and Forecasts (2018-2029)
• 1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

• 2.1 Global Polydeoxyribonudeotide (PDRN) Production Market Share by Manufacturers (2018-2023)
• 2.2 Global Polydeoxyribonudeotide (PDRN) Production Value Market Share by Manufacturers (2018-2023)
• 2.3 Global Key Players of Polydeoxyribonudeotide (PDRN), Industry Ranking, 2021 VS 2022
• 2.4 Global Polydeoxyribonudeotide (PDRN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 2.5 Global Polydeoxyribonudeotide (PDRN) Average Price by Manufacturers (2018-2023)
• 2.6 Global Key Manufacturers of Polydeoxyribonudeotide (PDRN), Manufacturing Base Distribution and Headquarters
• 2.7 Global Key Manufacturers of Polydeoxyribonudeotide (PDRN), Product Offered and Raw Material Status
• 2.8 Global Key Manufacturers of Polydeoxyribonudeotide (PDRN), Establish Date
• 2.9 Polydeoxyribonudeotide (PDRN) Market Competitive Situation and Trends
  • 2.9.1 Polydeoxyribonudeotide (PDRN) Market Concentration Rate
  • 2.9.2 Global 3 and 5 Largest Polydeoxyribonudeotide (PDRN) Players Market Share by Revenue
• 2.10 Mergers & Acquisitions, Expansion

3 Polydeoxyribonudeotide (PDRN) Production by Region

• 3.1 Global Polydeoxyribonudeotide (PDRN) Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
• 3.2 Global Polydeoxyribonudeotide (PDRN) Production Value by Region (2018-2029)
  • 3.2.1 Global Polydeoxyribonudeotide (PDRN) Production Value Market Share by Region (2018-2023)
  • 3.2.2 Global Forecasted Production Value of Polydeoxyribonudeotide (PDRN) by Region (2024-2029)
• 3.3 Global Polydeoxyribonudeotide (PDRN) Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
• 3.4 Global Polydeoxyribonudeotide (PDRN) Production by Region (2018-2029)
  • 3.4.1 Global Polydeoxyribonudeotide (PDRN) Production Market Share by Region (2018-2023)
  • 3.4.2 Global Forecasted Production of Polydeoxyribonudeotide (PDRN) by Region (2024-2029)
• 3.5 Global Polydeoxyribonudeotide (PDRN) Market Price Analysis by Region (2018-2023)
• 3.6 Global Polydeoxyribonudeotide (PDRN) Production and Value, Year-over-Year Growth
  • 3.6.1 Europe Polydeoxyribonudeotide (PDRN) Production Value Estimates and Forecasts (2018-2029)
  • 3.6.2 China Polydeoxyribonudeotide (PDRN) Production Value Estimates and Forecasts (2018-2029)
  • 3.6.3 South Korea Polydeoxyribonudeotide (PDRN) Production Value Estimates and Forecasts (2018-2029)

4 Polydeoxyribonudeotide (PDRN) Consumption by Region

• 4.1 Global Polydeoxyribonudeotide (PDRN) Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
• 4.2 Global Polydeoxyribonudeotide (PDRN) Consumption by Region (2018-2029)
  • 4.2.1 Global Polydeoxyribonudeotide (PDRN) Consumption by Region (2018-2029)
  • 4.2.2 Global Polydeoxyribonudeotide (PDRN) Forecasted Consumption by Region (2024-2029)
• 4.3 North America
  • 4.3.1 North America Polydeoxyribonudeotide (PDRN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
  • 4.3.2 North America Polydeoxyribonudeotide (PDRN) Consumption by Country (2018-2029)
  • 4.3.3 U.S.
  • 4.3.4 Canada
• 4.4 Europe
  • 4.4.1 Europe Polydeoxyribonudeotide (PDRN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
  • 4.4.2 Europe Polydeoxyribonudeotide (PDRN) Consumption by Country (2018-2029)
  • 4.4.3 Italy
  • 4.4.4 France
• 4.5 Asia Pacific
  • 4.5.1 Asia Pacific Polydeoxyribonudeotide (PDRN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
  • 4.5.2 Asia Pacific Polydeoxyribonudeotide (PDRN) Consumption by Region (2018-2029)
  • 4.5.3 China
  • 4.5.4 South Korea

5 Segment by Type

• 5.1 Global Polydeoxyribonudeotide (PDRN) Production by Type (2018-2029)
  • 5.1.1 Global Polydeoxyribonudeotide (PDRN) Production by Type (2018-2023)
  • 5.1.2 Global Polydeoxyribonudeotide (PDRN) Production by Type (2024-2029)
  • 5.1.3 Global Polydeoxyribonudeotide (PDRN) Production Market Share by Type (2018-2029)
• 5.2 Global Polydeoxyribonudeotide (PDRN) Production Value by Type (2018-2029)
  • 5.2.1 Global Polydeoxyribonudeotide (PDRN) Production Value by Type (2018-2023)
  • 5.2.2 Global Polydeoxyribonudeotide (PDRN) Production Value by Type (2024-2029)
  • 5.2.3 Global Polydeoxyribonudeotide (PDRN) Production Value Market Share by Type (2018-2029)
• 5.3 Global Polydeoxyribonudeotide (PDRN) Price by Type (2018-2029)

6 Segment by Application

• 6.1 Global Polydeoxyribonudeotide (PDRN) Sales by Application (2018-2029)
  • 6.1.1 Global Polydeoxyribonudeotide (PDRN) Sales by Application (2018-2023)
  • 6.1.2 Global Polydeoxyribonudeotide (PDRN) Sales by Application (2024-2029)
  • 6.1.3 Global Polydeoxyribonudeotide (PDRN) Sales Market Share by Application (2018-2029)
• 6.2 Global Polydeoxyribonudeotide (PDRN) Sales Value by Application (2018-2029)
  • 6.2.1 Global Polydeoxyribonudeotide (PDRN) Sales Value by Application (2018-2023)
  • 6.2.2 Global Polydeoxyribonudeotide (PDRN) Sales Value by Application (2024-2029)
  • 6.2.3 Global Polydeoxyribonudeotide (PDRN) Sales Value Market Share by Application (2018-2029)
• 6.3 Global Polydeoxyribonudeotide (PDRN) Price by Application (2018-2029)

7 Key Companies Profiled

• 7.1 HTL Biotechnology
  • 7.1.1 HTL Biotechnology Polydeoxyribonudeotide (PDRN) Company Information
  • 7.1.2 HTL Biotechnology Polydeoxyribonudeotide (PDRN) Product Portfolio
  • 7.1.3 HTL Biotechnology Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023)
  • 7.1.4 HTL Biotechnology Main Business and Markets Served
  • 7.1.5 HTL Biotechnology Recent Developments/Updates
• 7.2 ReaLi Tide Biological
  • 7.2.1 ReaLi Tide Biological Polydeoxyribonudeotide (PDRN) Company Information
  • 7.2.2 ReaLi Tide Biological Polydeoxyribonudeotide (PDRN) Product Portfolio
  • 7.2.3 ReaLi Tide Biological Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023)
  • 7.2.4 ReaLi Tide Biological Main Business and Markets Served
• 7.3 PharmaResearch Co., Ltd.
  • 7.3.1 PharmaResearch Co., Ltd. Polydeoxyribonudeotide (PDRN) Company Information
  • 7.3.2 PharmaResearch Co., Ltd. Polydeoxyribonudeotide (PDRN) Product Portfolio
  • 7.3.3 PharmaResearch Co., Ltd. Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023)
  • 7.3.4 PharmaResearch Co., Ltd. Main Business and Markets Served
  • 7.3.5 PharmaResearch Co., Ltd. Recent Developments/Updates
• 7.4 Humedix
  • 7.4.1 Humedix Polydeoxyribonudeotide (PDRN) Company Information
  • 7.4.2 Humedix Polydeoxyribonudeotide (PDRN) Product Portfolio
  • 7.4.3 Humedix Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023)
  • 7.4.4 Humedix Main Business and Markets Served
• 7.5 Ruijiming Biological
  • 7.5.1 Ruijiming Biological Polydeoxyribonudeotide (PDRN) Company Information
  • 7.5.2 Ruijiming Biological Polydeoxyribonudeotide (PDRN) Product Portfolio
  • 7.5.3 Ruijiming Biological Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023)
  • 7.5.4 Ruijiming Biological Main Business and Markets Served
  • 7.5.5 Ruijiming Biological Recent Developments/Updates
• 7.6 HENGYU BIOPH
  • 7.6.1 HENGYU BIOPH Polydeoxyribonudeotide (PDRN) Company Information
  • 7.6.2 HENGYU BIOPH Polydeoxyribonudeotide (PDRN) Product Portfolio
  • 7.6.3 HENGYU BIOPH Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023)
  • 7.6.4 HENGYU BIOPH Main Business and Markets Served
• 7.7 Mastelli
  • 7.7.1 Mastelli Polydeoxyribonudeotide (PDRN) Company Information
  • 7.7.2 Mastelli Polydeoxyribonudeotide (PDRN) Product Portfolio
  • 7.7.3 Mastelli Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023)
  • 7.7.4 Mastelli Main Business and Markets Served
• 7.8 Dongkook
  • 7.8.1 Dongkook Polydeoxyribonudeotide (PDRN) Company Information
  • 7.8.2 Dongkook Polydeoxyribonudeotide (PDRN) Product Portfolio
  • 7.8.3 Dongkook Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023)
  • 7.8.4 Dongkook Main Business and Markets Served
  • 7.8.5 Dongkook Recent Developments/Updates
• 7.9 BR PHARM
  • 7.9.1 BR PHARM Polydeoxyribonudeotide (PDRN) Company Information
  • 7.9.2 BR PHARM Polydeoxyribonudeotide (PDRN) Product Portfolio
  • 7.9.3 BR PHARM Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023)
  • 7.9.4 BR PHARM Main Business and Markets Served
• 7.10 BMI KOREA
  • 7.10.1 BMI KOREA Polydeoxyribonudeotide (PDRN) Company Information
  • 7.10.2 BMI KOREA Polydeoxyribonudeotide (PDRN) Product Portfolio
  • 7.10.3 BMI KOREA Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023)
  • 7.10.4 BMI KOREA Main Business and Markets Served
  • 7.10.5 BMI KOREA Recent Developments/Updates
• 7.11 BNF Solution
  • 7.11.1 BNF Solution Polydeoxyribonudeotide (PDRN) Company Information
  • 7.11.2 BNF Solution Polydeoxyribonudeotide (PDRN) Product Portfolio
  • 7.11.3 BNF Solution Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023)
  • 7.11.4 BNF Solution Main Business and Markets Served
  • 7.11.5 BNF Solution Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

• 8.1 Polydeoxyribonudeotide (PDRN) Industry Chain Analysis
• 8.2 Polydeoxyribonudeotide (PDRN) Key Raw Materials
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
• 8.3 Polydeoxyribonudeotide (PDRN) Production Mode & Process
• 8.4 Polydeoxyribonudeotide (PDRN) Sales and Marketing
  • 8.4.1 Polydeoxyribonudeotide (PDRN) Sales Channels
  • 8.4.2 Polydeoxyribonudeotide (PDRN) Distributors
• 8.5 Polydeoxyribonudeotide (PDRN) Customers

9 Polydeoxyribonudeotide (PDRN) Market Dynamics

• 9.1 Polydeoxyribonudeotide (PDRN) Industry Trends
• 9.2 Polydeoxyribonudeotide (PDRN) Market Drivers
• 9.3 Polydeoxyribonudeotide (PDRN) Market Challenges
• 9.4 Polydeoxyribonudeotide (PDRN) Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

• 11.1 Methodology/Research Approach
  • 11.1.1 Research Programs/Design
  • 11.1.2 Market Size Estimation
  • 11.1.3 Market Breakdown and Data Triangulation
• 11.2 Data Source
  • 11.2.1 Secondary Sources
  • 11.2.2 Primary Sources
• 11.3 Author List
• 11.4 Disclaimer